1. Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases
   Davor Galusic et al, 2022 CrossRef
2. Novel 7-Chloro-4-Aminoquinoline-Benzimidazole Hybrids as Inhibitors of Cancer Cells Growth: Synthesis, Antiproliferative Activity, in Silico ADME Predictions, and Docking
   Luka Krstulović et al, 2023, Molecules CrossRef
3. Revisiting the Role of Alkylating Agents in Multiple Myeloma: Up-to-Date Evidence and Future Perspectives
   Bruno Almeida Costa et al, 2023, Critical Reviews in Oncology/Hematology CrossRef
4. LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair
   Jianli Zhou et al, 2023, Oncotarget CrossRef
5. Novel Fluorescent Benzimidazole-Hydrazone-Loaded Micellar Carriers for Controlled Release: Impact on Cell Toxicity, Nuclear and Microtubule Alterations in Breast Cancer Cells
   Rayna Bryaskova et al, 2023, Pharmaceutics CrossRef
6. Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy
   Yutaka Shimazu et al, 2023, Ann Hematol CrossRef
7. Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?
   Dimitrios Filioglou et al, 2023, Front. Immunol. CrossRef
8. Treatment-Related Risk Factors for Adverse Outcomes of COVID-19 in Patients Treated for Lymphoid Malignancies in the Pre-Omicron Era—A Study of KroHem, the Croatian Group for Hematologic Diseases
   Igor Aurer et al, 2024, Biomedicines CrossRef
9. Bendamustine as a Cause of Drug-Associated Bullous Pemphigoid—A Rare Side Effect
   Preema Sinha et al, 2024 CrossRef
10. Post-marketing risk analysis of bendamustine: a real-world approach based on the FAERS database
    Dan Li et al, 2024, Front. Pharmacol. CrossRef
11. Nanoparticle-mediated metronomic chemotherapy in cancer: A paradigm of precision and persistence
    Apoorv Kirti et al, 2024, Cancer Letters CrossRef
12. null
    Jorge L. Mejía-Méndez et al, 2024 CrossRef
13. Advancements in the impact of human microbiota and probiotics on leukemia
    Yi Zhang et al, 2024, Front. Microbiol. CrossRef